SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

26 hedge funds and large institutions have $81.9M invested in Sierra Oncology, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.53%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
6
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
Bridgeway Capital Management
Texas
$425K
2
Northern Trust
Northern Trust
Illinois
$421K
3
IC
Ikarian Capital
Texas
$118K
4
Renaissance Technologies
Renaissance Technologies
New York
$1.14M
5
TRCT
Tower Research Capital (TRC)
New York
$74K

Top Sellers

1
VA
VR Adviser
New York
$4.59M
2
MP
Mangrove Partners
Connecticut
$5.1M
3
SCM
Sio Capital Management
New York
$0
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$237K
5
Victory Capital Management
Victory Capital Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SCM
26
Sio Capital Management
New York
– -$151K -15,395 Closed
Victory Capital Management
27
Victory Capital Management
Texas
– -$30K -2,954 Closed
1
2